These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179 [Abstract] [Full Text] [Related]
3. Chromosomal imbalances detected by array comparative genomic hybridization in human oligodendrogliomas and mixed oligoastrocytomas. Kitange G, Misra A, Law M, Passe S, Kollmeyer TM, Maurer M, Ballman K, Feuerstein BG, Jenkins RB. Genes Chromosomes Cancer; 2005 Jan 01; 42(1):68-77. PubMed ID: 15472895 [Abstract] [Full Text] [Related]
4. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors. Shukla B, Agarwal S, Suri V, Pathak P, Sharma MC, Gupta D, Sharma BS, Suri A, Halder A, Sarkar C. Neurol India; 2009 Jan 01; 57(5):559-66. PubMed ID: 19934553 [Abstract] [Full Text] [Related]
6. Correlation between genetic alteration and long-term clinical outcome of patients with oligodendroglial tumors, with identification of a consistent region of deletion on chromosome arm 1p. Hashimoto N, Murakami M, Takahashi Y, Fujimoto M, Inazawa J, Mineura K. Cancer; 2003 May 01; 97(9):2254-61. PubMed ID: 12712480 [Abstract] [Full Text] [Related]
7. Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker? Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A, German Glioma Network. Clin Cancer Res; 2007 Dec 01; 13(23):6933-7. PubMed ID: 18056167 [Abstract] [Full Text] [Related]
9. Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Franco-Hernández C, Martínez-Glez V, de Campos JM, Isla A, Vaquero J, Gutiérrez M, Casartelli C, Rey JA. Cancer Genet Cytogenet; 2009 Apr 15; 190(2):93-6. PubMed ID: 19380026 [Abstract] [Full Text] [Related]
14. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. McDonald JM, See SJ, Tremont IW, Colman H, Gilbert MR, Groves M, Burger PC, Louis DN, Giannini C, Fuller G, Passe S, Blair H, Jenkins RB, Yang H, Ledoux A, Aaron J, Tipnis U, Zhang W, Hess K, Aldape K. Cancer; 2005 Oct 01; 104(7):1468-77. PubMed ID: 16088966 [Abstract] [Full Text] [Related]
15. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses. Magnani I, Moroni RF, Roversi G, Beghini A, Pfundt R, Schoenmakers EF, Larizza L. Cancer Genet Cytogenet; 2005 Sep 01; 161(2):140-5. PubMed ID: 16102584 [Abstract] [Full Text] [Related]
17. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, Hosek SM, Kimmel D, O'Fallon J, Yates A, Feuerstein BG, Burger PC, Scheithauer BW, Jenkins RB. Oncogene; 1999 Jul 15; 18(28):4144-52. PubMed ID: 10435596 [Abstract] [Full Text] [Related]
18. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Tews B, Roerig P, Hartmann C, Hahn M, Felsberg J, Blaschke B, Sabel M, Kunitz A, Toedt G, Neben K, Benner A, von Deimling A, Reifenberger G, Lichter P. Oncogene; 2007 Jul 26; 26(34):5010-6. PubMed ID: 17311001 [Abstract] [Full Text] [Related]